NuVasive Announces Major Insurance Providers Reverse Policy on Minimally Disruptive Spinal Fusion Procedure
Major commercial insurance providers have recently reversed their policies on the minimally disruptive eXtreme Lateral Interbody Fusion (XLIF) procedure, a groundbreaking treatment for spine-related issues. NuVasive, the developer of the XLIF procedure, announced that CIGNA and Humana have joined the list of insurance providers that now cover the procedure. This change marks a significant victory for patients suffering from spine-related issues, who can now have access to the minimally invasive treatment. Alex Lukianov, NuVasive's Chairman and CEO, expressed his appreciation for the efforts of surgeons, surgical societies, and insurance companies in making this technology available to those in need.
Key Takeaways:
- All major commercial insurance providers that previously had non-coverage policies for XLIF have reversed their position, including Aetna, United Healthcare, Health Care Service Corporation, Humana, and CIGNA.
- The XLIF procedure, a minimally disruptive surgical product, has been developed by NuVasive to treat spine-related issues with minimal tissue disruption.
- The Maximum Access Surgery (MAS) platform, developed by NuVasive, combines four categories of products that minimize tissue disruption, maximize visualization, and ensure safe and easy reproducibility for the surgeon.
- NuVasive's MAS platform has been successful in reducing surgery time and allowing patients to return to daily activities much faster than conventional approaches.
- The company has built an entire spine franchise with over 65 products spanning lumbar, thoracic, and cervical applications, with a focus on R&D and outstanding service levels.
Statistics:
- The global spine market is valued at $7.7 billion.
- NuVasive is the 5th largest player in the global spine market.
- The company's MAS platform has minimized tissue disruption during spine surgery.
- Marketwire reports that NuVasive has built an entire spine franchise with over 65 products.
Sources:
- NuVasive, Inc. press release, "NuVasive Announces CIGNA and Humana Reverse Policy on Minimally Disruptive Spinal Fusion Procedure" (January 18, 2011)
- Marketwire, Inc. (January 18, 2011)